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Edited by Robert BaroukiAbstract We examined the mRNA levels of hypoxia-inducible
factor-1a (HIF-1a) in bone marrow mesenchymal stem cells
(bmMSCs) of eight osteoarthritis patients. BmMSC-1, express-
ing higher HIF-1a mRNA and protein than bmMSC-5, elicited
higher matrix metalloproteinase-1 (MMP1) activity and stron-
ger invasive capacity. In vitro invasion assays and quantitative
PCR analyses showed that targeted inhibition of HIF-1a in
bmMSC-1 decreased its invasion and expressions of MMP1
and MMP3, whereas overexpression of HIF-1a in bmMSC-5 in-
creased its invasion and expressions of MMP1 and MMP3.
Therefore, HIF-1a can regulate MMP1 and MMP3 expressions
in human bmMSCs, which might suggest a pathophysiological
role of bmMSC expressing high HIF-1a in bone diseases.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Hypoxia-inducible factor-1 (HIF-1) is an oxygen-labile hete-
rodimeric transcription factor composed of HIF-1a and HIF-
1b subunits. Cellular HIF-1a level is regulated by cellular oxy-
gen concentrations, hence acting as the regulatory subunit of
HIF-1 [1]. HIF-1 can transactivate a number of genes whose
products participate in glucose uptake, erythropoietin synthe-
sis, angiogenesis, etc. Thus, HIF-1 is the major factor main-
taining oxygen homeostasis, which is crucial in embryonic
development, healing of ischemic wounds, and even tumor
progression [2,3]. These ﬁndings suggest that HIF-1 may play
a physiological or pathophysiological role depending on its
expression levels in diﬀerent cell types.
In bone marrow, the mesenchymal stem cell (bmMSC) is a
small population of cells capable of self-renewal proliferation
and lineage diﬀerentiation into chondrocyte, osteoblast, adipo-
cyte, myoblast, and ﬁbroblast [4–7], and is believed to play aAbbreviations: HIF-1a, hypoxia-inducible factor-1a; siRNA, small
interfering RNA; GFP, green ﬂuorescence protein; MMP, matrix
metalloproteinase; APMA, p-aminophenylmercuric acetate
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doi:10.1016/j.febslet.2008.06.033key role in bone regeneration and maintenance of adult bone
mass. In addition, bmMSCs are also featured by their capabil-
ity of targeted migration [8 and references therein], which has
paved way for bmMSCs to serve as an ideal tool for therapeu-
tic gene delivery in tissue repair. Other studies have shown that
matrix metalloproteases (MMPs) produced by bmMSCs play
an important role in their targeted migration [9]. However,
how the expression of MMPs is regulated in bmMSCs is still
not well addressed.
Previously, we and the other research group reported that
HIF-1a can enhance invasive capacity of human cancer cells
[10,11], indicating that HIF-1a may regulate the cellular prote-
olytic activities. In the present study, we examined the expres-
sion of HIF-1a in bmMSCs isolated from old donors, and
studied the link between HIF-1a and expression of MMPs.2. Materials and methods
2.1. Cell culture and treatment
Human bone marrow samples were collected from osteoarthritis pa-
tients (69–77 years old). Informed consent was obtained from each do-
nor. The use of human bmMSCs in this study was approved by both
the Institutional Review Board at National Health Research Institutes
and hospital. To isolate bmMSCs, marrow aspirate was diluted with
equal volume of Dulbeccos phosphate-buﬀered saline (DPBS), and
then transferred on top of 10 ml of Ficoll (Amersham Biosciences) in
a 50-ml conical tube. Cell separation was accomplished by centrifuga-
tion at 1100 · g for 30 min at 20 C. The nucleated cells were collected
from the interface, diluted with two volumes of DPBS, and collected
by centrifugation at 900 · g. The cells were plated in a 10-cm culture
plate, and cultured in Dulbeccos modiﬁed Eagles medium (DMEM)
(low glucose) (GIBCO-BRL) containing 10% fetal bovine serum
(FBS) (Hyclone), glutamine (GIBCO-BRL), penicillin and streptomy-
cin (GIBCO-BRL), and maintained in a humidiﬁed atmosphere con-
taining 5% CO2 at 37 C. Cells were passaged at 70–80% conﬂuence.
Cells of the fourth passage were subjected to ﬂow cytometric analysis,
and those that were CD31- and CD45-negative, but CD90- and
CD105-positive were deﬁned as bmMSCs. For hypoxic treatment, cells
(4 · 105) plated in 10-cm culture dishes were incubated in 6 ml medium
as mentioned above, and maintained in a humidiﬁed atmosphere con-
taining 2% O2, 2% CO2, and 96% N2 at 37 C for 4 h. For overexpres-
sion or inhibition of HIF-1a, pCEP4/HIF-1a (American Type Culture
Collection, ATCC) or siRNAHIF-1a was transfected into bmMSCs,
respectively, by electroporation using MicroPorator system (NanoEn-
Tek Inc., South Korea) following the protocol provided by manufac-
turer. The sequences of siRNAs were as follows: siRNAHIF-1a
(sense), AGAGGUGGAUAUGUGUGGGdTdT; siRNAHIF-1a (anti-
sense), CCCACACAUAUCCACCUCUdTdT; siRNAGFP (sense),
GGCUACGUCCAGGAGCGCACC; and siRNAGFP (antisense),
UGCGCUCCUGGACGUAGCCUU.blished by Elsevier B.V. All rights reserved.
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Cells (1 · 106) were washed with PBS and collected by centrifuga-
tion. Cell pellet was suspended into 150 ll cold RIPA buﬀer plus pro-
tease inhibitors for 30 min, and then subjected to centrifugation to
collect supernatant. Aliquots (40 lg) of whole-cell lysates were sepa-
rated on 10% SDS–polyacrylamide gels, and electrotransferred onto
polyvinylidene membranes. The membranes were incubated with
anti-HIF-1a (BD Biosciences, catalog no. 610959) and anti-a-tubulin
(Neo markers, catalog no. MS-581-P1) antibodies, and the signals were
obtained by enhanced chemiluminescence (PIERCE).
2.3. In vitro invasion and migration assays
Quantitative Cell Migration Assay Collagen I system (Chemicon
International) was used to examine invasion and migration of
bmMSCs. Brieﬂy, cells (1.6 · 104) were suspended in 0.5 ml medium
and added to the upper chamber which was lodged into the lower
chamber containing 0.75 ml medium. After incubating at 37 C for
the time as indicated, the cells in the upper chamber were removed with
cotton swabs. The membranes were then soaked in the ﬁxation solu-
tion for 10 min and then stained with Liu stain. The stained cells were
counted in three ﬁelds under a microscope.
2.4. RNA isolation and RT-PCR
Total RNA was isolated from bmMSCs and subjected to RT-PCRs
for detection of HIF-1a expression as described previously [11]. The 5 0
and 3 0 primers used in PCRs were as follows: HIF-1a (479 bp),
AGAAAAAGATAAGTTCTGAACGTC and GAGAAAAAAGCT-
TCGCTGTGTG; and GAPDH (597 bp), CCACCCATGGCA-
AATTCCATGGCA and TCTAGACGGCAGGTCAGGTCCACC.
The PCR products were resolved in 2% agarose gels and then stained
with ethidium bromide. Signals were visualized with an AlphaImager
(Alpha Innotech).
2.5. Quantitative real-time PCR
Real-time qPCR was performed using the Power SYBR Green PCR
Master Mix (Applied Biosystems, CA). The 5 0 and 3 0 primers used
were as follows: MMP1 (154 bp), GATGGACCTGGAGGAAATC
and GTCCAAGAGAATGGCCGA; MMP2 (400 bp), CACTGAGG-
GCCGCACGGAT and CTTGATGTCATGCTGGGACA; MMP3
(152 bp), CGCCTGTCTCAAGATGATATAAAT and CTGACA-
GCATCAAAGGACAA; MMP14 (186 bp), GGTGTTTGAT-
GAGGCGT and GGGTACTCGCTATCCACT; and b-actin
(71 bp), CCCTGGCACCCAGCAC and GCCGATCCACACGGAG-
TAC. Primers for HIF-1a were as described above. All real-time
qPCRs were performed in triplicate on an ABI PRISM 7000 Sequence
Detector System as follows: 50 C for 2 min, 95 C for 10 min and 40
cycles of 15 s at 95 C and 1 min at 60 C. The relative mRNA levels
were calculated using the 2DDCT method, with b-actin mRNA as a
normalizer.
2.6. Conditioned medium preparation
Cells (1.5 · 105) were seeded into 6-cm tissue culture plates and
maintained in the original medium for 24 h. Then cells were washed
with PBS and cultured in 1.5 ml serum-free medium for 24 h. Then
the medium was collected and stored at 80 C.
2.7. Matrix metalloproteinase-1 activity assay
The levels of endogenous free active MMP1 and total free MMP1 in
the conditioned media were determined using a MMP1 Biotrak Activ-
ity Assay System (Amersham Biosciences) following the protocol pro-
vided by the manufacturer. Brieﬂy, 100 ll of each standard (proMMP1
provided by the manufacturer) and conditioned media were incubated
at 4 C for 16 h in microplate wells precoated with anti-MMP1 anti-
body which binds pro and active MMP1. The wells were washed four
times with wash buﬀer and aspirated. Fifty microliters of p-aminophe-
nylmercuric acetate (APMA) solution plus 50 ll detection reagent was
added into the wells containing standards or conditioned medium to
measure the total (pro and active) MMP1 activity. On the other hand,
50 ll of assay buﬀer (without APMA) plus 50 ll detection reagent was
added into the wells containing conditioned medium to measure the
endogenous active MMP1. The plates were read at 405 nm immedi-
ately and 3 h after incubating at 37 C. The endogenous active
MMP1 as well as total MMP1 contents were determined by interpola-tion from the standard curve. The resulting data were used to calculate
the relative level of MMP1 in media.
2.8. Statistical analysis
Data shown were the means ± S.D. Statistical diﬀerence between
two groups was determined by paired t-test. A value of P < 0.05 was
considered to denote statistical signiﬁcance.3. Results
We performed RT-PCR analyses to examine HIF-1amRNA
levels in bmMSCs obtained from old donors. Data showed that
cellular HIF-1amRNA levels varied among bmMSC cells (Fig.
1A). We chose bmMSC-1 and bmMSC-5 for subsequent stud-
ies because of the dramatic diﬀerence of the HIF-1amRNA lev-
els between these two cultures. Quantitative PCR showed that
HIF-1a mRNA level of bmMSC-1 was approximately 3-folds
of that of bmMSC-5 (Fig. 1B). Western blot analyses showed
that under normoxic condition HIF-1a protein level of
bmMSC-1 was approximately 2.5-folds of that of bmMSC-5
(Fig. 1C). Hypoxia increased HIF-1a protein in both bmMSCs.
Next, we performed in vitro invasion assays to examine the
invasive capability of bmMSC-1 and bmMSC-5. Data showed
that the invasive activity of bmMSC-1, as measured using col-
lagen I-coated ﬁlter membranes, was 2-folds of that of
bmMSC-5, whereas the migratory activity of bmMSC-1, as
measured using BSA-coated ﬁlter membranes, was similar to
that of bmMSC-5 (Fig. 1D). These data showed that
bmMSC-1 expressed more HIF-1a and was more invasive than
bmMSC-5. Accordingly, we studied the role of HIF-1a in the
invasiveness of bmMSCs. As shown, overexpression of HIF-
1a (63% increase) caused approximately 60% increase in the
invasiveness of bmMSC-5 (Fig. 2A). On the other hand, inhibi-
tion of HIF-1a expression (57% decrease) using siRNAHIF-1a
caused approximately 35% decrease in the invasiveness of
bmMSC-1 (Fig. 2B). These data showed a functional link be-
tween HIF-1a and invasion of bmMSCs.
That bmMSC-1 was more eﬃciently in migrating through
collagen I-coated ﬁlter membranes than bmMSC-5 implied
that bmMSC-1 might produce more MMP1 than bmMSC-5.
Thus, RNA isolated from bmMSC-5 and bmMSC-1 was sub-
jected to real-time qPCR analyses. Results showed that the
MMP1 mRNA level of bmMSC-1 was approximately 5.7-folds
of that of bmMSC-5 (Fig. 3A). Moreover, ELISA assays
showed that the levels of total free MMP1 and endogenous ac-
tive MMP1 in bmMSC-1-derived conditioned media were
approximately 5-folds and 2-folds of those of bmMSC-5 de-
rived media, respectively (Fig. 3B and C), indicating that
bmMSC-1 produced more MMP1 and elicited higher MMP1
activity than bmMSC-5.
Thus, we studied if HIF-1a regulated MMP1 expression in
bmMSCs. Complementary DNAs prepared from the various
bmMSC-1 and bmMSC-5 cultures used in the experiments of
Fig. 2 were subjected to real-time qPCRs to examine the
mRNA levels of HIF-1a and several MMPs. As shown, the
mRNA levels of HIF-1a, MMP1, and MMP3 (a MMP1 acti-
vator) in pCEP4/HIF-1a-transfected bmMSC-5 were approxi-
mately 2.6-, 1.6-, and 1.9-folds of those of untreated bmMSC-5
(Fig. 4A). The levels of these mRNAs in siRNAHIF-1a-trans-
fected bmMSC-1 were approximately 66%, 69%, and 61% of
those of untreated bmMSC-1 (Fig. 4B). In comparison, expres-
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Fig. 1. HIF-1a expression and invasive activity of human bmMSCs. (A) Two micrograms of RNA prepared from each bmMSC culture was
subjected to RT-PCR analyses to show the levels of HIF-1a mRNA of these cultures. GAPDH served as a control. (B) Equal amount of cDNA
(0.5 lg) prepared from bmMSC-1 and bmMSC-5 were subjected to real-time qPCR assays to detect HIF-1a mRNA and b-actin mRNA (as a
normalizer). The DCT value of bmMSC-1 was calibrated against that of bmMSC-5 to obtain the DDCT value. The level of HIF-1a mRNA of
bmMSC-1 was presented relatively to that of bmMSC-5. Data represent the means ± S.D. from three experiments. (C) Whole-cell lysates prepared
from normoxic (N) bmMSC-1 and bmMSC-5 cultures were subjected to Western blot analyses to measure the relative abundance of HIF-1a protein.
Cell lysates from hypoxic (H) cultures served as positive controls. Signals were quantitated, and the HIF-1a/a-tubulin values were calculated. The
level of HIF-1a protein of bmMSC-1 was presented relatively to that of bmMSC-5. Data represent the means ± S.D. from three experiments. (D)
BmMSC-1 and bmMSC-5 (1.6 · 104 each) were seeded on collagen I-coated, and BSA-coated ﬁlter membranes. These cells were incubated for 24 h at
37 C. Cells migrated through the ﬁlter membranes were counted under a 40-fold high power ﬁeld. Cell counts of bmMSC-5 and bmMSC-1 that
migrated through collagen I- and BSA-coated membranes were 71 ± 19, 142 ± 66, 117 ± 49, and 140 ± 60 cells, respectively. Data represent the
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Fig. 2. HIF-1a regulated invasive activity of bmMSCs. BmMSC-5 (1.2 · 106) were transfected with 2 lg of pCEP4/HIF-1a (HIF-1a) or pGFP
(GFP) (A), whereas bmMSC-1 (1.2 · 106) were transfected with 100 nM of siRNAHIF-1a (siHIF-1a) or siRNAGFP (siGFP) (B). A part of cells were
harvested 40 h after transfection for Western blot analyses (left panels), and for real-time qPCRs (see Fig. 4). Meanwhile, a part of cells (1.6 · 104
each) were seeded on collagen I-coated and BSA-coated ﬁlter membranes 16 h after transfection. Subsequent invasion and migration assays were
performed as described in Fig. 1D. Cell counts of the plasmid- or siRNA-transfected cells were compared with those of untreated cells to obtain the
relative invasion and migration activities. Data represent the means ± S.D. from three experiments. *P < 0.05 and #P < 0.01 versus control.
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bmMSC-1 were not aﬀected by the manipulation of HIF-1a
expression. Taken together, our data indicated that HIF-1a
could up-regulate the expression of MMP1, and possibly its
activity by inducing MMP3 expression in bmMSCs.4. Discussion
Our investigation revealed that the basal expression of HIF-
1a in bmMSCs of old human subjects varies among subjects,
and that the elevated HIF-1a can up-regulate at least the


































































Fig. 3. Measurement of MMP1 expression and activity. (A) Equal
amount of cDNA (0.5 lg) prepared from bmMSC-1 and bmMSC-5
were subjected to real-time qPCR assays to detect MMP1 mRNA and
b-actin mRNA (as a normalizer). The nCT value of bmMSC-1 was
calibrated against that of bmMSC-5 to obtain the DDCT value. The
level of MMP1 mRNA of bmMSC-1 was presented relatively to that of
bmMSC-5. Data represent the means ± S.D. from three experiments.
In addition, bmMSC-1 and bmMSC-5 (1.5 · 105 each) were cultured in
1.5 ml serum-free medium to generate conditioned media. Two batches
of media were prepared. These media were subjected to ELISA
analyses for the levels of total free MMP1 (B) and endogenous active
MMP1 (C). The concentrations of total free and endogenous active
MMP1 of bmMSC-1 were 2.9 ± 0.14 and 0.43 ± 0.08 ng/ml, and those
of bmMSC-5 were, 0.58 ± 0.07 and 0.23 ± 0.04 ng/ml, respectively. The
levels of total free and endogenous active MMP1 of bmMSC-1 were
compared with those of bmMSC-5 to obtain relative MMP1 levels.
Data represent the means ± S.D. from four triplicate analyses.
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vated HIF-1a expression in the biological properties of
bmMSCs has not been deﬁned, it is reasonable to assume that






















Fig. 4. HIF-1a regulated MMP1 and MMP3 expression in bmMSCs. A p
experiments of Fig. 2 were used to prepare cDNA. Equal amount of cDNA (0
were subjected to real-time qPCR analyses to measure the levels of HIF-1a, M
normalizer. The DCT values of the plasmid- or siRNA-transfected cells were c
levels of HIF-1a, MMP1, MMP2, MMP3, and MMP14 mRNAs of the pla
untreated cells. Data represent the means ± S.D. from three analyses. *P < 0ischemic stress more successfully because HIF-1a can mediate
cellular adaptive response to hypoxia [3]. It was reported that
the vascular function and limb blood ﬂow are reduced with
age, which lowers oxygen level in tissues and represents a risk
factor of age-related diseases [12]. So, it is reasonable to spec-
ulate that bmMSCs with high HIF-1a level may be less aﬀected
by low oxygen level associated with aging. Whether high HIF-
1a/MMP1 production may aﬀect the migratory activity of
bmMSCs in the collagen I-rich bone marrow microenviron-
ments during the recruitment of bmMSC is not clear. How-
ever, based on our data (Fig. 2), it is likely to occur. Since
hypoxia increases HIF-1a expression, our data suggest that
HIF-1a-induced MMP1 and MMP3 may participate in hypox-
ia-promoted bmMSC migration. A somewhat diﬀerent result
was reported that hypoxia promotes migration of MSCs
mainly through inducing MMP14 [13]. For the signaling medi-
ating bmMSC migration per se, it has been reported that Wnt/
b-catenin signaling plays an important role in the migratory
capacity of human bmMSCs [8]. Our data reveal that the com-
plicated mechanisms underlying bmMSC migration may also
include HIF-1a-related signaling.
Elevated HIF-1a up-regulates MMP1 and MMP3 expres-
sion in bmMSCs. So then, could it play a role in the pathogen-
esis and/or progression of osteoarthritis? Our study design
does not provide data directly addressing this question partly
because the bone marrow donors are all aged osteoarthritis pa-
tients. However, it has been shown that HIF-1 may initiate hy-
poxia-induced apoptosis by increasing the expression of
BNIP3 and/or by stabilizing p53 [14]. Moreover, Komatsu et
al. reported that partial HIF-1a deﬁciency enhances bone
regeneration in vivo by decreasing the apoptosis of osteoblast
and chondrocyte [15]. These ﬁndings suggest that in spite of
being a cell survival signal, higher level of HIF-1a may cause
pathological eﬀects, especially when certain target genes are
excessively induced. Using MMP1 as an example, while low le-
vel of MMP1 may participate in healthy tissue remodeling, its
level is elevated in arthritic tissues. Based on current theory,
osteoarthritis is the consequence of long term mechanical
stress on the articular cartilage. In response, the cartilage chon-
drocytes produce inﬂammatory cytokines and MMPs includ-
ing MMP1, which eventually causes destruction of articular
cartilage [16,17]. So, under pathological conditions, excess pro-
duction of MMP1 by chondrocytes may facilitate the destruc-
tion of cartilage and development of osteoarthritis. Given that
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.5 lg) from various bmMSC-5 cultures (A) and bmMSC-1 cultures (B)
MP1, MMP2, MMP3, and MMP14 mRNAs with b-actin mRNA as a
alibrated against that of untreated cells to obtain the DDCT values. The
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.05 versus control.
J.-L. Lin et al. / FEBS Letters 582 (2008) 2615–2619 2619reasonable to assume that a subclass of bmMSCs expressing
higher HIF-1a/MMP1/MMP3 is more likely to play a critical
role in the progression of osteoarthritis and other bone dis-
eases. Further characterization of the impact of high HIF-1a
expression to the lineage diﬀerentiation of bmMSCs and to
the proteolytic performance of bmMSC-derived progeny will
shed light on the question regarding the putative pathophysio-
logical role of bmMSCs expressing high HIF-1a in bone dis-
eases.
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